Does a verapamil-trandolapril-based strategy improve clinical effectiveness compared to an atenolol-hydrochlorothiazide-based strategy in hypertensive CAD patients?
A verapamil-trandolapril-based strategy is as clinically effective as an atenolol-hydrochlorothiazide-based strategy in patients with hypertension and coronary artery disease.
The verapamil-trandolapril-based strategy was as clinically effective as the atenolol-hydrochlorothiazide-based strategy in hypertensive CAD patients.
Pepine et al. (Tue,) studied this question.